Ligand validation:7BS7

ANL: ANILINE

ANL is a Ligand Of Interest in 7BS7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BS7_ANL_A_303	30%	93%	0.225	0.889	0.17	0.31	-	-	3	0	100%	1
7BS7_ANL_A_302	25%	98%	0.181	0.813	0.08	0.17	-	-	0	0	100%	0.61
7BS7_ANL_A_307	2%	99%	0.336	0.635	0.08	0.16	-	-	0	0	100%	1
5MNC_ANL_A_307	69%	49%	0.136	0.951	1.12	0.87	1	-	1	0	100%	0.67
5MNA_ANL_A_303	56%	51%	0.148	0.921	1.01	0.9	1	1	0	0	100%	1
1HJ9_ANL_A_246	19%	12%	0.17	0.764	1.13	2.89	1	5	0	0	100%	1
3GUN_ANL_A_168	80%	72%	0.101	0.95	0.59	0.49	-	-	1	0	100%	0.5
2OV4_ANL_A_950	28%	0%	0.224	0.876	7.18	3.31	7	7	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.